<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-15559</identifier>
<setSpec>0214-3941</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Do the efficacy and safety of low molecular weight heparins (LMWH) depend on the anti-Fxa and anti-FIIa activity? Other antithombotic activities of the LMWH</dc:title>
<dc:creator>Martínez Brotons, F</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Ediciones Doyma, S.L.</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev. iberoam. trombos. hemost. (Ed. impr.);13(2): 63-68, jun. 2000. tab</dc:source>
<dc:identifier>ibc-15559</dc:identifier>
<dc:title xml:lang="es">¿La eficacia y seguridad de las heparinas de bajo peso molecular (HBPM) dependen de la actividad anti-FXa y anti-FIIa? Otras actividades antitrombóticas de las HBPM</dc:title>
<dc:subject>^d27942^s22044</dc:subject>
<dc:subject>^d22270^s22006</dc:subject>
<dc:subject>^d932^s22073</dc:subject>
<dc:subject>^d22311^s22031</dc:subject>
<dc:subject>^d14312^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d31696^s22073</dc:subject>
<dc:subject>^d31696^s22078</dc:subject>
<dc:subject>^d932^s22078</dc:subject>
<dc:subject>^d6622^s22027</dc:subject>
<dc:subject>^d23425^s22031</dc:subject>
<dc:subject>^d31696^s22079</dc:subject>
<dc:subject>^d24646^s22006</dc:subject>
<dc:subject>^d24709</dc:subject>
<dc:type>article</dc:type>
<dc:date>200006</dc:date>
</metadata>
</record>
</ibecs-document>
